| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Institut de Biochimie Clinique, University of Geneva Geneva, Switzerland
Abstract
45Ca++ efflux studies were performed on rat islets of Langerhans which were loaded to isotopic equilibrium during 48 h in tissue cultures. 45Ca++ loading was 50% complete at 1 h, 80% at 4 h, and reached, at equilibrium, a content equal to 10–11 pmol/islet.
The islets responded to glucose stimulation with a rapid and markedly biphasic insulin release. Under normal conditions, glucose stimulated 45Ca++ efflux with an initial surge (simultaneous with the first peak of insulin release), which declined rapidly to 50% of the peak value and then slowly declined for the remainder of the glucose stimulation. Special conditions were required to uncover an early inhibition of 45Ca++ efflux; these were the lowering of the temperature of the perifusate from 37 C to 30 C or below, or reduction of the medium Ca++ concentration to 0.1 mM or less. Under zero calcium conditions the glucose inhibition of 45Ca++ efflux can be rigorously interpreted as an inhibition of calcium efflux.
The studies at low temperature or low Ca++ concentrations revealed two effects of glucose on 45Ca++ efflux: an initial inhibition followed by a stimulation, the inhibitory effect was obscured by the rapidity of onset of the stimulatory effect under normal conditions. At low temperature it was also possible to inhibit glucose-stimulated insulin release, although the stimulated 45Ca++ efflux remained unchanged. At 30 C or in experiments with 0.3 mM Ca++, glucose-stimulated insulin release preceded the stimulation of 45Ca++ efflux. It therefore, is, concluded that the stimulated 45Ca++ efflux is a consequence, rather than a determinant, of stimulussecretion coupling. The stimulated efflux is dependent on the presence of Ca++ in the medium and is independent of emiocytosis. This latter finding excludes the secretory granules as a significant source of glucose-stimulated 45Ca++ extrusion. (Endocrinology 102: 1339, 1978)
Footnotes
* This work was supported by the Swiss National Science Foundation (Grant 3.1060.73).
To whom requests for reprints should be addressed at: Institut de Biochimie Clinique, Sentier de la Roseraie, 1211 Geneve 4, Switzerland.
Received July 21, 1977.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |